This author asserts that the pharaceutical interests likely interfered with the FDA. At the time of the congression hearings, Revici technologies were perceived as threat to the pharmaceutical industry’s methodone product.
Revici’s nutrient blends were called “Perse” during the testimony. Eventually the FDA refused to grant drug approval to all of Dr. Revici’s formulas.
Later, DSHEA was passed, and Dr. Revici’s formulas became “Dietary Supplements”. In the meantime, his innovatations “died at the hands of the FDA”. Here is a Blog that discusses “Perse vs Methadone”.
Here is the history of how the FDA responded to congress illustrating stall tactics. Final inaction by the FDA illustrates contempt of congress by the FDA.
Here are a series of excerpts from complete congressional testimony (53 MB), showing:
- Congressman Ass Chewing the FDA for inaction
- Perse Preliminary Study
- Dr. Casriel Clinic Results
- Dr. Davidson Perse Testimony
- New York State Testifies it’s inaction
- Dr. Casriel’s Case Against Methadone
These addiction kits work. They are experimental, and membership is required, including informed consent for use of an experimental products. They are distributed as “Detoxification Systems”, under Dietary Supplement Health and Education Act.
